News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Rahul Gosain: HemeSeries, with Naveen Pemmaraju we discuss treatment options and current landscape of Myelofibrosis
A collage photo of Rahul Gosain and Naveen Pemmaraju
May 22, 2024, 03:21

Rahul Gosain: HemeSeries, with Naveen Pemmaraju we discuss treatment options and current landscape of Myelofibrosis

Rahul Gosain, Director of Regional Infusion Services at 

“HemeSeries: with Naveen Pemmaraju we discuss treatment options and current landscape of Myelofibrosis.

Full discussion, Also on the ‘Oncology Brothers’ podcast.”

Additional information.
Proceed to video attached to post.
Source: Rahul Gosain/LinkedIn

 

cancer HemeSeries myelofibrosis Naveen Pemmaraju OncoDaily Oncology Oncology Brothers Rahul Gosain Wilmot Cancer Institute
Special Coverage
Blog
Dec 18, 2024, 18:42
Antonio Giordano: Dana-Farber’s CCTI team expanding interests and growing with Glenn J. Hanna leadership
Blog
Dec 18, 2024, 18:36
Stacey Tinianov on quality of life with patients while discussing new therapies
Blog
Dec 18, 2024, 18:34
Razelle Kurzrock: Pleasure to give talk for Cancer Precision Medicine Commons
Blog
Dec 18, 2024, 18:31
Yao Zhu: Honored to join Journal of Clinical Oncology as an editor
Science
Dec 18, 2024, 18:28
Yannick R.: The changing global landscape of national cancer control plans
Blog
Dec 18, 2024, 18:24
Triparna Sen: Grateful to have been invited as a speaker at the LALCA24
Blog
Dec 18, 2024, 18:20
Angie Rolle: ACS is seeking a results-driven leader to join as Vice President - Community Impact
Insight
Dec 18, 2024, 18:18
"2024's top 10 advances in medicine" suggested by Samuel Hume
Blog
Dec 18, 2024, 18:12
Divij Verma: The increased risk of pre-leukemic clonal hematopoiesis in 9/11-exposed first responders
Blog
Dec 18, 2024, 18:09
Narjust Florez: Our EQUAL study is about to launch
Blog
Dec 18, 2024, 18:05
The Adoption of the IASLC 9th Edition TNM Classification System for Lung Cancer
Blog
Dec 18, 2024, 18:02
ASCO25 is the place to be innovative